Healthcare & Life Science

KO client Okogen, a clinical stage ophthalmic pharmaceutical company specializing in innovative eyecare solutions, recently announced the successful closing of $3.3 million in financing. According to the announcement, the funding will advance the company through the completion of the Phase 2b clinical program for acute infectious conjunctivitis (AIC) and the…

KO client ClinOne, which connects, informs, and empowers participants, care partners, and sites in clinical trials with a true single platform for trial awareness, consent management, and participant experience and retention, was recently acquired by uMotif, one of the clinical research technology market’s fastest-growing companies. “We’re excited to integrate our…

KO client Cloudbreak Pharma, an innovative clinical-stage ophthalmology biotechnology company, recently announced that it has entered into a licensing agreement with Santen, a specialized company dedicated to eye health, to develop, manufacture, and commercialize its topical pterygium treatment. Cloudbreak founder and CEO Jinsong Ni said: “We are excited to partner…

KO client Calorify, a metabolic testing startup, recently announced that it has raised nearly $500,000 in a pre-seed round to expand its work with clinical trials, medical practices, and professional sports teams. With the funding, Calorify plans to execute its go-to-market plan for its metabolic testing kit that the company…

KO client ABOUT Healthcare, a portfolio company of Rubicon Technology Partners and a leading provider of SaaS-based hospital operations solutions for admission management and post-acute placement, recently acquired Edgility, an AI and analytics platform company that monitors and manages operations in real time, resulting in optimized capacity, enhanced patient progression,…

Congratulations to KO Law partner Brad Schoenfeld on being recognized as one of the “Top 25 Attorneys of Colorado” by Attorney Intel. Brad and the selected attorneys exemplify the depth of legal talent in Colorado and have specialized practices in a number of areas. Over the last 20 years at…

KO client Predicine, Inc., a leading molecular insights company committed to advancing precision medicine in oncology, recently announced a collaboration with Janssen Pharmaceutica NV, a Johnson & Johnson company, to develop PredicineCARE™ as a companion diagnostic assay in localized bladder cancer. The collaboration represents progress in using comprehensive genomic profiling…

In the unpredictable world of business, there is one constant and unwelcome companion lurking in the shadows: risk. We find risk anywhere and everywhere in a business environment: research and development, personnel matters, physical operations, customer relationships, data and security, and many other facets of running a business. Despite a…